Reports N Reports

The Grow of 22.3% CAGR for Global Human Microbiome Market to 2023

Press Release   •   Sep 12, 2014 05:45 EDT

Need for early diagnosis and efficient treatment with microbiome therapy for maintaining healthy lifestyle will boost the human microbiome market

The product segment is expected to account for the largest share of the human microbiome market in the coming years. The high growth in this segment is attributed to the expectations to bring promising microbiome products to the market to help individual for the treatment of chronic diseases and various disorders at early stages and also due to increased curiosity among people to stay fit and have healthy lifestyle. The ability of these products to combat the fatal lifestyle diseases and maintain good health among the diseased population with the use of effective microbiome-based drugs and diagnostics devices will influence the market growth.

 Complete report available @ .

Europe currently forms the largest human microbiome market in terms of demand for prebiotics and probiotics. The APAC region is expected to register the highest growth rate due to its immense growth opportunities and manufacturing cost benefits, while the U.S. is comparatively underdeveloped. Scientific evidence of health benefits of certain ingredients such as probiotics, prebiotics, etc. and the search for new opportunities to add value to the existing products are also expected to propel the global market growth. The demand for prebiotics and probiotics is increasing across various regions owing to the awareness among consumers regarding the favorable benefits of the microbiome community also referred as "friendly" bacteria. Most of the consumers prefer these products for maintaining good health and to use enhanced efficiency of ingredients, which offer products with bio-therapeutic properties. With the advancement in technology, the usage of probiotics is likely to extend beyond the current arena of gut, dental, and immune health to several other areas of human health.

Moreover, rising incidences of cardiac diseases and other diseases such as diabetes and obesity are also expected to contribute to the growth of the human microbiome market. Increasing side effects and diminishing of human gut flora, due to excessive use of antibiotics, is likely to drive the growth of the human microbiome market. The application market is also expected to be a prominent segment owing to the use of microbiome as diagnostics and therapeutics. The evidence from intransigent research resulted the use of microbiomes as biomarkers and diagnosis of various diseases.

The disease segment, on the other hand, will be the fastest-growing segment in the coming years. With the growing incidences and increasing awareness of lifestyle diseases this market is set to grow at a fast pace.

Inquire for Discount on price $4650 @ .

The grey area while estimating the market size was the uncertainty factor that lies with the current regulatory scenario for various products. The insights were provided by the industry experts who later clarified as to which disease segment will witness product approvals by the regulatory authorities and will enter the market in the future.

From an insight perspective, this research report focuses on the qualitative data, future market size, share, and market potential of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats) and technological trends, globally. It mainly focuses on the emerging and high-growth segments of the human microbiome market and the initiatives of their respective governments.

The competitive landscape covers the current product pipelines of the industry players in various stages of the clinical trial development. The company profiles comprise the basic views on the key players in the human microbiome market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future.

The above mentioned market research data, market potential, future market size, and forecast of future trends will help the key players and new entrants to make the necessary decisions regarding market penetration, product development/innovation, market development, market diversification, and competitive assessment, product offerings, geographic focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful in the market.

Table of Contents

1 Introduction
1.1 Objectives Of The Study
1.2 Report Description
1.2.1 Markets Covered
1.3 Stakeholders
1.4 Market Scope

2 Research Methodology
2.1 Market Size Estimation
2.2 Market Crackdown & Data Triangulation
2.3 Market Share Estimation

3 Executive Summary

4 Premium Insights
4.1 Attractive Market Opportunities In Human Microbiome Market
4.2 Market Snapshot
4.3 North Ameria Will Be The Fastest Growing Market In The Forecast Period
4.4 Market: By Diseases
4.5 Market: By Product
4.6 Life Cycle Analysis, By Geography
4.7 Human Microbiome Market: By Application

5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics

6 Industry Trends
6.1 Introduction
6.2 Industry Trends
6.3 Porter’s Five Forces Analysis
6.4 Pest Analysis
6.5 Strategic Benchmarking

7 Human Microbiome Market, By Disease
7.1 Introduction
7.2 Diabetes
7.3 Obesity
7.4 Autoimmune Disorder
7.5 Cancer
7.6 Acute Diarrhea
7.7 Mental Disorder
7.8 Others

8 Human Microbiome Market, By Application
8.1 Introduction
8.2 Therapeutic
8.3 Diagnostics

9 Market, By Product
9.1 Introduction
9.2 Probiotic
9.3 Prebiotic
9.4 Foods
9.5 Medical Food
9.6 Other Probiotic Supplements
9.7 Devices
9.8 Drugs

10 Geographic Analysis
10.1 Introduction
10.2 North America
10.3 Europe
10.4 Asia-Pacific
10.5 Rest Of The World (Row)

11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situation And Trends

12 Company Profiles
12.1 Introduction
12.2 Enterome Bioscience
12.3 Second Genome, Inc.
12.4 Microbiome Therapeutics Llc.
12.5 Vedanta Biosciences
12.6 Metabiomics Corporation
12.7 E. I. Du Pont De Nemours And Company
12.8 Merck & Co., Inc.
12.9 Yakult Honsha Co., Ltd.
12.10 Osel Inc.
12.11 Vithera Pharmaceuticals

Purchase a copy of this report (Single user license: US $4650) @ . provides market research reports to industries, individuals and organizations with an objective of helping them in their decision making process. Our library of 400,000+ industry & country research reports covers 5000+ micro markets.